Cancer Chemotherapy and Pharmacology Journal Citation Rate 2026
0344-5704
eISSN 1432-0843
Springer Science+Business Media
DE
Q2 Quartile
About Cancer Chemotherapy and Pharmacology
Cancer Chemotherapy and Pharmacology (CCP) is a peer-reviewed academic journal covering Cancer Treatment and Pharmacology and Cancer therapeutics and mechanisms, published by Springer Science+Business Media in DE, catalogued under ISSN 0344-5704 (e-ISSN 1432-0843). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.98 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$3990 USD). OpenAlex records 9,877 works and 275,739 citations, with an h-index of 154.
Cancer Chemotherapy and Pharmacology Citation Rate 2026 — In Context
Cancer Chemotherapy and Pharmacology has a 2025 2-Year Citation Rate (OpenAlex) of 1.98, placing it in the Q2 quartile within the Cancer Treatment and Pharmacology research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Cancer Chemotherapy and Pharmacology operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Cancer Chemotherapy and Pharmacology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Cancer Chemotherapy and Pharmacology against similar journals in the field, use our journal comparison tool.
Submission Tips for Cancer Chemotherapy and Pharmacology
- Budget $3990 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Cancer Treatment and Pharmacology, Cancer therapeutics and mechanisms, Colorectal Cancer Treatments and Studies. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Cancer Chemotherapy and … Compares
Compared against 19 journals in the same research areas.
| ISSN (Print) | 0344-5704 |
|---|---|
| ISSN (Online) | 1432-0843 |
| Publisher | Springer Science+Business Media |
| Country | Germany |
| APC / Cost | $3990 USD |
In-depth profile & metrics
Cancer Chemotherapy and Pharmacology is published by Springer Science+Business Media and based in Germany. It runs on a subscription or hybrid model with an article-processing charge of USD 3990.
In our subject taxonomy, Cancer Chemotherapy and Pharmacology is classified under Cancer Treatment and Pharmacology, Cancer therapeutics and mechanisms, Colorectal Cancer Treatments and Studies and Lung Cancer Research Studies.
Cancer Chemotherapy and Pharmacology is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 1.977.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Cancer Chemotherapy and Pharmacology
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 1.977 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Cancer Chemotherapy and Pharm… against similar publications in its field:
Related Journals in Your Field
-
Drugs Adis, Springer Healthcare IF 9.72
-
European Journal of Medicinal Chemistry Elsevier IF 4.62
-
Critical Reviews in Oncology/Hematology Elsevier BV IF 4.62
-
Journal of Cancer Research and Clinical Oncology Springer Science+Business Media IF 4.16
-
Bioorganic Chemistry Elsevier BV IF 3.85
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S117498271
Get weekly updates for Cancer Treatment and Pharmacology journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.